News
The latest news from the CyberGene team
CyberGene acquires a new patent
CyberGene acquires new patent
CyberGene AB has acquired a patent for prenatal diagnostics of the Chromosome 22q11.2 deletion syndrome associated with congenital heart disease (CHD)
ESHG Conference
The ESHG 2022 conference is taking place in Vienna, June 10-13.
We are excited to finally meet the research community, customer and partners face-to-face again.
Contact us at sales@cybergene.se to book a meeting.
Want to get started?
CyberGene supports your lab from start to routine diagnostics